Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 4, 2019, the Board of Directors of the Bioanalytical Systems, Inc. (the "Company") approved an amendment (the "Amendment") to the Company's 2018 Equity Incentive Plan (as amended by the Amendment, the "Plan"), and submittal of the Amendment to the shareholders for their consideration and approval. On March 19, 2020, at the Company's 2020 annual meeting of shareholders, the shareholders of the Company approved the Amendment. The Amendment is described on pages 11 through 15 of the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on January 28, 2020. This description is incorporated herein by reference and is qualified in its entirety by reference to the full text of the Plan, which was filed as Annex A to the Company's Definitive Proxy Statement on Schedule 14A and is incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders

On March 19, 2020, the Company held its annual meeting of shareholders. A total of 7,487,543 shares of the Company's common stock outstanding and entitled to vote were present at the meeting in person or by proxy. The following is a summary of the matters voted on at the meeting.

a.) One Class II member of the Board of Directors were elected to serve a


     three-year term ending in 2023 with the following votes cast:




Nominee                        For      Withheld   Broker Non-Vote

Richard A. Johnson, Ph.D.   4,636,902    690,504         2,160,137

b.) The appointment of RSM US LLP as our independent registered public


     accountants for fiscal 2020 was ratified by the following shareholder vote:




                            Vote Type       Voted
                            For             7,379,917
                            Against           100,235
                            Abstain             7,391

c.) The proposal to approve an amendment to the 2018 Equity Incentive Plan,


     passed with the following votes cast:




                    Vote Type                  Voted
                    For                             4,893,898
                    Against                           415,533
                    Abstain                            17,975
                    Broker Non-votes                2,160,137

© Edgar Online, source Glimpses